NM_024675.4(PALB2):c.3350+2C>A AND Familial cancer of breast

Germline classification:: Likely pathogenic (1 submission)
Last evaluated:: Sep 15, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003450445.1

Allele description [Variation Report for NM_024675.4(PALB2):c.3350+2C>A]

NM_024675.4(PALB2):c.3350+2C>A

Gene:

PALB2:partner and localizer of BRCA2 [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

16p12.2

Genomic location:

Preferred name:

NM_024675.4(PALB2):c.3350+2C>A

HGVS:

NC_000016.10:g.23607862G>T
NG_007406.1:g.38496C>A
NM_001407296.1:c.3290+2C>A
NM_001407297.1:c.3278+2C>A
NM_001407298.1:c.3188+2C>A
NM_001407299.1:c.3114-4193C>A
NM_001407300.1:c.3071+2C>A
NM_001407301.1:c.3202-4193C>A
NM_001407302.1:c.3040-4193C>A
NM_001407304.1:c.2465+2C>A
NM_001407305.1:c.2465+2C>A
NM_001407306.1:c.2465+2C>A
NM_001407307.1:c.2303+2C>A
NM_001407308.1:c.2229-4193C>A
NM_001407309.1:c.2229-4193C>A
NM_001407310.1:c.2317-4193C>A
NM_001407311.1:c.2317-4193C>A
NM_001407312.1:c.1562+2C>A
NM_001407313.1:c.1414-4193C>A
NM_001407314.1:c.884+2C>A
NM_024675.4:c.3350+2C>AMANE SELECT
LRG_308:g.38496C>A
NC_000016.9:g.23619183G>T

Molecular consequence:

NM_001407299.1:c.3114-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407301.1:c.3202-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407302.1:c.3040-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407308.1:c.2229-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407309.1:c.2229-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407310.1:c.2317-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407311.1:c.2317-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407313.1:c.1414-4193C>A - intron variant - [Sequence Ontology: SO:0001627]
NM_001407296.1:c.3290+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407297.1:c.3278+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407298.1:c.3188+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407300.1:c.3071+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407304.1:c.2465+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407305.1:c.2465+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407306.1:c.2465+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407307.1:c.2303+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407312.1:c.1562+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_001407314.1:c.884+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]
NM_024675.4:c.3350+2C>A - splice donor variant - [Sequence Ontology: SO:0001575]

Condition(s)

Name:: Familial cancer of breast
Synonyms:: Breast cancer, familial; Hereditary breast cancer
Identifiers:: MONDO: MONDO:0016419; MedGen: C0346153; OMIM: 114480

Recent activity

Clear Turn Off Turn On

Homo sapiens peripheral myelin protein 2 (PMP2), transcript variant 1, mRNA
Homo sapiens peripheral myelin protein 2 (PMP2), transcript variant 1, mRNA
gi|1143077036|ref|NM_002677.4|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004188418	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Likely pathogenic (Sep 15, 2023)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004188418

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Likely pathogenic
(Sep 15, 2023)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004188418.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered likely pathogenic. This variant occurs within a consensus splice junction and is predicted to result in abnormal mRNA splicing of either an out-of-frame exon or an in-frame exon necessary for protein stability and/or normal function.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 8, 2024

ClinVar

Relating variation to medicine